Barclays’s Xtant Medical Holdings XTNT Stock Holding History

Barclays’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79	Buy	+187	New	+$90	﹤0.01%	5212
2025 Q4	–	Sell	-8	Closed	-$5	–	5767
2025 Q3	$5	Buy	+8	New	+$5	﹤0.01%	5416
2021 Q2	–	Sell	-2,951	Closed	-$7K	–	5108
2021 Q1	$7K	Buy	+2,951	New	+$6.3K	﹤0.01%	4472
2020 Q3	–	Sell	-20	Closed	–	–	5635
2020 Q2	$0	Buy	+20	New	+$18	﹤0.01%	6339
2018 Q4	–	Sell	-2	Closed	–	–	7394
2018 Q3	$0	Sell	2 -388	-99%	-$2.05K	﹤0.01%	7438
2018 Q2	$2K	Buy	+390	New	+$2.61K	﹤0.01%	6854

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Barclays's XTNT Position: Q2 2026 in Review

Barclays opened a new position in Xtant Medical Holdings (XTNT) in Q2 2026: 187 shares worth $79. The stake represents ﹤0.01% of the portfolio and ranks #5212 among its holdings. This is a return to the name: Barclays previously reported a position in XTNT as recently as Q3 2025.

Barclays first reported a position in XTNT in Q2 2018 and has held it in 6 quarters since. The position peaked at $7K in Q1 2021. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Barclays held 187 shares of Xtant Medical Holdings worth $79 as of Q2 2026.
Xtant Medical Holdings was a new Barclays position in Q2 2026.
Xtant Medical Holdings made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5212 holding.
Barclays first reported a position in Xtant Medical Holdings in Q2 2018 and has held it in 6 quarters since.
Barclays's Xtant Medical Holdings position peaked at $7K in Q1 2021.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.